Egypt Edition 
MENA+ Edition 
UAE Edition 
Saudi Edition 
AI + Innovation (MENA) 
Logistics (MENA) 
Read Full Issue Ibnsina Pharma has increased its issued capital to EGP 205 mn from EGP 180.5 mn by issuing EGP 24.5 mn-worth of bonus shares, according to an EGX disclosure (pdf).
Egypt’s Ibnsina raises issued capital to EGP 205 mn via bonus shares
Share
Share
More from Enterprise
Banking
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Finance
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
Capital Markets
Why EGX stocks are going under the IPO wave
Fund managers are releasing liquidity for ongoing and future IPOs,…
Fintech
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…